Donor-lymphocyte infusion (DLI) after hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCY) as GVHD prevention treatment

被引：0

作者：

Gallo, Susanna ^{[1
]}

Caravelli, Daniela ^{[1
]}

Becco, Paolo ^{[1
]}

Polo, Alessandra ^{[2
]}

Salierno, Milena ^{[2
]}

Giancaspero, Karol ^{[2
]}

Scalabrini, Delia Rota ^{[1
]}

Sangiolo, Dario ^{[3
]}

Vassallo, Elena ^{[4
]}

Frascione, Pio Manlio Mirko ^{[1
]}

Poletto, Stefano ^{[1
]}

Paruzzo, Luca ^{[1
]}

Crotto, Luca ^{[5
]}

Aglietta, Massimo ^{[1
]}

Fagioli, Franca ^{[4
]}

Schianca, Fabrizio Carnevale ^{[1
]}

机构：

[1] IRCCS, Candiolo Canc Inst FPO, Turin Metropolitan Transplant Ctr, Med Oncol, Candiolo, Italy

[2] IRCCS, Candiolo Canc Inst FPO, Collect & Proc Lab, Candiolo, Italy

[3] IRCCS, Candiolo Canc Inst FPO, Med Oncol, Candiolo, Italy

[4] Osped Infantile Regina Margherita, AOU Citta Salute & Sci Torino, Turin Metropolitan Transplant Ctr, Pediat Oncohematol, Turin, Italy

[5] IRCCS, Candiolo Canc Inst FPO, Clin Res Off, Candiolo, Italy

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P073

引用

页码：189 / 190

页数：2

共 50 条

[21] Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis
J. D. Marra
E. Galli
S. Giammarco
P. Chiusolo
E. Metafuni
F. Sora
L. Laurenti
I. Innocenti
F. Autore
M. A. Limongiello
A. Fresa
A. Bacigalupo
S. Sica
[J]. Bone Marrow Transplantation, 2023, 58 : 1042 - 1044
[22] Post-transplant cyclophosphamide for GVHD prophylaxis in matched unrelated donor transplantation
Bailen, Rebeca
Jesus Pascual-Cascon, Maria
Balsalobre, Pascual
Sanz, Jaime
Doblas-Marquez, Alberto
Benitez-Hidalgo, Olga
Luis Pinana, Jose
Bento, Leyre
Sampol, Antonia
Oarbeascoa, Gillen
Solan, Laura
Dorado, Nieves
Martinez-Laperche, Carolina
Anguita, Javier
Buno, Ismael
Luis Diez-Martin, Jose
Kwon, Mi
[J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 88 - 88
[23] CD3 Lymphocyte Graft Content and Not Hematopoietic Stem Cell Source Is Associated to Higher Chronic GVHD after Haploidentical Transplantation with Post-Transplant Cyclophosphamide
Mussetti, Alberto
De Philippis, Chiara
Carniti, Cristiana
Oreiro, Mariana Bastos
Gayoso, Jorge
Cieri, Nicoletta
Ciceri, Fabio
Greco, Raffaella
Patriarca, Francesca
Mariotti, Jacopo
Castagna, Luca
Corradini, Paolo
[J]. BLOOD, 2017, 130
[24] Alternative Donor Hematopoietic Stem Cell Transplantation (HSCT) with Post-transplant Cyclophosphamide in Patients with Inherited Disorders
Bykova, Tatiana
Osipova, Anna
Ovetchkina, Varvara
Dotcenko, Anna
Galimov, Alexander
Alyanskiy, Alexander
Moiseev, Ivan
Kulagin, Alexander
Semenova, Elena
Zubarovskaya, Ludmila
Afanasyev, Boris
[J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 671 - 672
[25] ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR NON-MALIGNANT DISORDERS
Klein, Orly
Chen, Allen
Robey, Nancy
Symons, Heather
[J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : S100 - S100
[26] Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation
Helg, C
Starobinski, M
Jeannet, M
Chapuis, B
[J]. LEUKEMIA & LYMPHOMA, 1998, 29 (3-4) : 301 - 313
[27] Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (±fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion
Lush, RJ
Haynes, AP
Byrne, JL
Cull, GM
Carter, GI
Pagliuca, A
Parker, JE
Mufti, G
Mahendra, P
Craddock, CF
Yin, JAL
Garg, M
Prentice, HG
Potter, MN
Russell, NH
[J]. CYTOTHERAPY, 2001, 3 (03) : 203 - 210
[28] Post-Relapse Survival after Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post Transplant Cyclophosphamide (PTCY): Potential Impact of DLI Post-Relapse
Solh, Melhem
Bashey, Asad
Solomon, Scott R.
Morris, Lawrence E.
Zhang, Xu
Holland, H. Kent
[J]. BLOOD, 2021, 138
[29] ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Penack, Olaf
Abouqateb, Mouad
Peczynski, Christophe
Boreland, William
Kroeger, Nicolaus
Stelljes, Matthias
Gedde-Dahl, Tobias
Blau, Igor Wolfgang
Schroeder, Thomas
Salmenniemi, Urpu
Kulagin, Alexander
de Latour, Regis Peffault
Mielke, Stephan
Zeiser, Robert
Moiseev, Ivan
Schoemans, Helene
Koenecke, Christian
Peric, Zinaida
[J]. LEUKEMIA, 2024, 38 (05) : 1156 - 1163
[30] ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Olaf Penack
Mouad Abouqateb
Christophe Peczynski
William Boreland
Nicolaus Kröger
Matthias Stelljes
Tobias Gedde-Dahl
Igor Wolfgang Blau
Thomas Schroeder
Urpu Salmenniemi
Alexander Kulagin
Régis Peffault de Latour
Stephan Mielke
Robert Zeiser
Ivan Moiseev
Hélène Schoemans
Christian Koenecke
Zinaida Peric
[J]. Leukemia, 2024, 38 : 1156 - 1163

← 1 2 3 4 5 →